Along these lines, it was shown that Nrf2 signaling enhances resistance of head and neck carcinoma cells to artesunate, whereas Nrf2 inhibition allows for efficient ferroptosis-induction in resistant head and neck cancer [42]. This evidence concerns the gene NFE2L2 and head and neck carcinoma.